Loading clinical trials...
Loading clinical trials...
A Multicenter Randomized Control Clinical Trail of Evaluating Effect of Demethylation Drug Combined With Chemotherapy in Patients With Intermediate-risk AML After Hematological Complete Remission
Conditions
Interventions
Decitabine and Ara-C
Ara-C
Locations
1
China
Nanfang Hospital of Southern Medical University
Guanzhou, Guangdong, China
Start Date
February 1, 2018
Primary Completion Date
January 31, 2022
Completion Date
January 31, 2025
Last Updated
April 27, 2020
NCT06852222
NCT06580106
NCT06501196
NCT06384261
NCT06382168
NCT06537726
Lead Sponsor
Xuejie Jiang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions